By Dr Amandine Ganon
Hemochromatosis is a genetic disorder characterized by iron overload, which can damage vital organs, particularly the liver. Advances in the understanding of iron metabolism have led to the identification of new forms not linked to the HFE gene. While biological diagnosis and treatment are straightforward, early detection remains essential to improving patient life expectancy.
So, what are the first- and second-line biological tests used to screen for hemochromatosis?
And in which patient profiles should genetic variants of hemochromatosis be investigated?
